AJP - Endo AJP: Regulatory, Integrative and Comparative Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 265: E880-E888, 1993;
0193-1849/93 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sasaki, A.
Right arrow Articles by Goldberg, I. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sasaki, A.
Right arrow Articles by Goldberg, I. J.

AJP - Endocrinology and Metabolism, Vol 265, Issue 6 E880-E888, Copyright © 1993 by American Physiological Society

ARTICLES

Lipoprotein lipase binding to adipocytes: evidence for the presence of a heparin-sensitive binding protein

A. Sasaki, P. Sivaram and I. J. Goldberg
Department of Medicine and Specialized Center of Research in Arteriosclerosis, Columbia University College of Physicians and Surgeons, New York, New York 10032.

Lipoprotein lipase (LPL) is synthesized by adipocytes, associated with the cell surface, and released from the cells when they are treated with heparin. Release of LPL from the adipocyte is required for LPL to migrate to its physiological site of action on the luminal surface of capillary endothelial cells. To better understand this process, we studied the interaction of LPL with adipocyte cell membrane proteins. With the use of a ligand blot method, LPL specifically bound to a heparin-releasable, 116-kDa protein on mouse-derived brown fat adipose cell (BFC-1 beta) and rat adipocyte membranes. A 116-kDa cell surface protein was metabolically labeled with [35S]methionine and bound to LPL-Sepharose. This suggested that the LPL-binding protein was synthesized by the cells. When BFC-1 beta were treated with heparin to eliminate heparin-sensitive cell surface binding sites, LPL binding to the cells decreased and release of newly synthesized LPL activity increased. 125I-labeled LPL binding to control cells was reduced (> 70%) by a 50-fold excess of unlabeled LPL. The residual LPL binding to heparin-treated cells was, however, not decreased by the addition of unlabeled LPL. These data imply that specific adipocyte surface LPL binding involves heparin-sensitive sites. We hypothesize that the heparin-releasable, 116-kDa LPL-binding protein mediates specific LPL binding to adipocytes and that LPL activity within adipose tissue is regulated, in part, by the interaction of LPL with this binding protein.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
T. Ruge, M. Bergo, M. Hultin, G. Olivecrona, and T. Olivecrona
Nutritional regulation of binding sites for lipoprotein lipase in rat heart
Am J Physiol Endocrinol Metab, February 1, 2000; 278(2): E211 - E218.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Pillarisetti, L. Paka, A. Sasaki, T. Vanni-Reyes, B. Yin, N. Parthasarathy, W. D. Wagner, and I. J. Goldberg
Endothelial Cell Heparanase Modulation of Lipoprotein Lipase Activity. EVIDENCE THAT HEPARAN SULFATE OLIGOSACCHARIDE IS AN EXTRACELLULAR CHAPERONE
J. Biol. Chem., June 20, 1997; 272(25): 15753 - 15759.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online